申请人:Charrier Jean Damien
                            
                            
                                公开号:US20100137359A1
                            
                            
                                公开(公告)日:2010-06-03
                            
                            The present invention provides a compound of formula I:
wherein:
X is —OR
1
or —N(R
5
)
2
,
Y is halo, trifluorophenoxy, or tetrafluorophenoxy;
R
l
is:
C
1-6
straight chained or branched alkyl, alkenyl, or alkynyl, wherein the alkyl, alkenyl, or alkynyl is optionally substituted with optionally substituted aryl, CF
3
, Cl, F, OMe, OEt, OCF
3
, CN, or NMe
2
;
C
1-6
cycloalkyl, wherein 1-2 carbon atoms in the cycloalkyl is optionally replaced with —O— or —NR
5
—;
R
2
is C
1-6
straight chained or branched alkyl;
R
3
is hydrogen, halo, OCF
3
, CN, or CF
3
;
R
4
is hydrogen, halo, OCF
3
, CN, or CF
3
; and
each R
5
is independently H, C
1-6
straight chained or branched alkyl, aryl, —O—C
1-6
straight chained or branched alkyl, or —O-aryl.
The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated disease, particularly in the central nervous system.
                            本发明提供一种化合物,其
化学式为I:其中:X为—OR1或—N(R5)2,Y为卤素,三
氟苯氧基或
四氟苯氧基;R1为C1-6直链或支链烷基,烯基或炔基,其中烷基,烯基或炔基可以选择性地被取代为选择性取代基的芳基,
CF3,Cl,F,OMe,OEt,O   ,CN或NMe2;C1-6环烷基,其中环烷基中的1-2个碳原子可以选择性地被取代为—O—或—NR5—;R2为C1-6直链或支链烷基;R3为氢,卤素,O   ,CN或   ;R4为氢,卤素,O   ,CN或   ;每个R5都是独立的H,C1-6直链或支链烷基,芳基,—O—C1-6直链或支链烷基或—O-芳基。本发明还提供了制备该化合物的药物组合物以及使用该组合物治疗半胱
氨酸
蛋白酶介导的疾病,特别是中枢神经系统疾病的方法。